// App-Quantinova.ai

P885 : PROSPECTIVE ASSESSMENT OF MYELOMA TUMOUR BURDEN AND BONE DISEASE USING DW-MRI AND EXPLORATORY BONE BIOMARKERS

Researchers

Presenter

  • Gaurav Agarwal

Principal Investigators

  • Guido Nador

  • Sherin Varghese

  • Hiwot Getu

  • Charlotte Palmer

  • Chris Rodgers

  • Claudio Pereira

  • Germana Sallemi

  • Neel Patel

  • Rajkumar Soundarajan

  • Rebecca Mills

  • Richard Brouwer

  • Aarti Shah

  • Delia Peppercorn

  • Claire Edwards

  • Muhammad Javaid

  • Sarah Gooding

  • Karthik Ramasamy

Medical Centers

  • University of Oxford,Oxford,Соединённое Королевство

  • Department of Clinical Neurosciences,University of Cambridge,Cambridge,United Kingdom

  • Department of Clinical Neurosciences,University of Cambridge,Cambridge,United Kingdom

  • University of Oxford,Oxford,Royaume-uni

  • University of Oxford,Oxford,Vereinigtes Königreich

  • University of Oxford,Oxford,Reino Unido

  • Department of Clinical Haematology,Oxford University Hospitals NHS Foundation Trust,Oxford,Vereinigtes Königreich

  • Department of Clinical Haematology,Oxford University Hospitals NHS Foundation Trust,Oxford,Vereinigtes Königreich

  • Nuffield Department of Orthopaedics Rheumatology and Musculoskeletal Sciences University of Oxford Oxford UK

  • University of Oxford,Oxford,Reino Unido

  • Department of Clinical Haematology, Oxford University Hospitals NHS Trust, Oxford ,

  • Nuffield Department of Orthopaedics Rheumatology and Musculoskeletal Sciences University of Oxford Oxford UK

  • Department of Radiology,Hampshire Hosp

  • Department of Haematology,Oxford University Hospitals NHS Foundation Trust,Oxford,Royaume-uni

  • The Nuffield Departm

  • Department of Radiology,Hampshire Hospitals NHS Foundation Trust,Hampshire,United Kingdom

  • Department of Cellular Pathology, Oxford University Hospitals NHS Foundation Trust, Oxford, United Kingdom

  • University of Oxford, Oxford, United Kingdom

  • Department of Radiology,Hampshire Hospitals NHS Foundation Trust,Hampshire,United Kingdom

  • Nuffield Department of Orthopaedics Rheumatology and Musculoskeletal Sciences University of Oxford Oxford UK

  • Department of Clinical Neurosciences,University of Cambridge,Cambridge,United Kingdom

  • Department of Haematology,Oxford University Hospitals NHS Foundation Trust,Oxford,Royaume-uni

  • Department of Haematology,Oxford University Hospitals NHS Foundation Trust,Oxford,Royaume-uni

  • Department of Clinical Neurosciences, University of Cambridge, UK

  • University of Oxford,Oxford,Storbritannien

  • Department of Clinical Neurosciences,University of Cambridge,Cambridge,United Kingdom

  • University of Oxford,Oxford,Verenigd Koninkrijk

  • Department of Radiology,Hampshire Hospitals NHS Foundation Trust,Hampshire,United Kingdom

  • Department of Haematology,Oxford University Hospitals NHS Foundation Trust,Oxford,Royaume-uni

  • Department of Radiology,Hampshire Hospitals NHS Foundation Trust,Hampshire,United Kingdom

Locations

  • United States

  • United Kingdom

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

  • Endocrine/metabolic Diseases (ME)

Disease

  • Multiple Myeloma

  • Monoclonal gammopathy

Biomarkers

  • Alkaline phosphatase

  • AKT Serine

  • Osteoprotegerin

  • C-Telopeptide of type 1 collagen

  • Receptor activator of nuclear factor kappa-Β ligand

  • Dickkopf-Related Protein 1

  • Apparent diffusion coefficient

  • Monoclonal gammopathy of undetermined significance

Drug/Treatment

  • N/A

Outcome

  • N/A

Study Design

  • Multinational

  • Prospective

Phase

  • N/A

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved